Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Fromtling

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Sabouraudia|September 1, 1983
In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139R A Fromtling, H P Yu, S Shadomy
Mycopathologia|May 1, 1988
Cryptococcus neoformans: a central nervous system isolate from an AIDS patient that is rhinotropic in a normal mouse modelR A Fromtling, G K Abruzzo, A Ruiz
Mycopathologia|June 1, 1989
Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto RicoR A Fromtling, G K Abruzzo, A Ruiz
Mycopathologia|January 30, 1981
Pseudohyphal forms of Cryptococcus neoformans: decreased survival in vivoJ B Neilson, R A Fromtling, G S Bulmer
Mycopathologia|March 15, 1984
Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymerR A Fromtling, H J Shadomy, A M Kaplan
Diagnostic Microbiology and Infectious Disease|January 1, 1990
Increasing usage of systemic antifungal agentsT J Walsh, P F Jarosinski, R A Fromtling
Infection and Immunity|September 1, 1977
Cryptococcus neoformans: size range of infectious particles from aerosolized soilJ B Neilson, R A Fromtling, G S Bulmer
Mycopathologia|July 23, 1982
Decreased virulence in stable, acapsular mutants of cryptococcus neoformansR A Fromtling, H J Shadomy, E S Jacobson
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1984
Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic miceR A Fromtling, G K Abruzzo, H H Gadebusch
Journal of Clinical Microbiology|August 1, 1987
Candida tropicalis infection in normal, diabetic, and neutropenic miceR A Fromtling, G K Abruzzo, D M Giltinan
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Sabouraudia|September 1, 1983
In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139R A Fromtling, H P Yu, S Shadomy
Mycopathologia|May 1, 1988
Cryptococcus neoformans: a central nervous system isolate from an AIDS patient that is rhinotropic in a normal mouse modelR A Fromtling, G K Abruzzo, A Ruiz
Mycopathologia|June 1, 1989
Virulence and antifungal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto RicoR A Fromtling, G K Abruzzo, A Ruiz
Mycopathologia|January 30, 1981
Pseudohyphal forms of Cryptococcus neoformans: decreased survival in vivoJ B Neilson, R A Fromtling, G S Bulmer
Mycopathologia|March 15, 1984
Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymerR A Fromtling, H J Shadomy, A M Kaplan
Diagnostic Microbiology and Infectious Disease|January 1, 1990
Increasing usage of systemic antifungal agentsT J Walsh, P F Jarosinski, R A Fromtling
Infection and Immunity|September 1, 1977
Cryptococcus neoformans: size range of infectious particles from aerosolized soilJ B Neilson, R A Fromtling, G S Bulmer
Mycopathologia|July 23, 1982
Decreased virulence in stable, acapsular mutants of cryptococcus neoformansR A Fromtling, H J Shadomy, E S Jacobson
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1984
Antibacterial efficacy of norfloxacin, trimethoprim-sulfamethoxazole, and gentamicin in experimentally-infected normal and streptozotocin-induced diabetic miceR A Fromtling, G K Abruzzo, H H Gadebusch
Journal of Clinical Microbiology|August 1, 1987
Candida tropicalis infection in normal, diabetic, and neutropenic miceR A Fromtling, G K Abruzzo, D M Giltinan
Pageof 7